OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Development of therapeutic antibodies for the treatment of diseases
Zeng Wang, Guoqing Wang, Huaqing Lu, et al.
Molecular Biomedicine (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 78
Zeng Wang, Guoqing Wang, Huaqing Lu, et al.
Molecular Biomedicine (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 78
Showing 1-25 of 78 citing articles:
Molecular Aspects of the Functioning of Pathogenic Bacteria Biofilm Based on Quorum Sensing (QS) Signal-Response System and Innovative Non-Antibiotic Strategies for Their Elimination
Edyta Juszczuk‐Kubiak
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2655-2655
Open Access | Times Cited: 25
Edyta Juszczuk‐Kubiak
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2655-2655
Open Access | Times Cited: 25
Therapeutic Antibodies in Medicine
Prerna Sharma, Rahul V. Joshi, Robert C. Pritchard, et al.
Molecules (2023) Vol. 28, Iss. 18, pp. 6438-6438
Open Access | Times Cited: 29
Prerna Sharma, Rahul V. Joshi, Robert C. Pritchard, et al.
Molecules (2023) Vol. 28, Iss. 18, pp. 6438-6438
Open Access | Times Cited: 29
De novo generation of SARS-CoV-2 antibody CDRH3 with a pre-trained generative large language model
Haohuai He, Bing He, Lei Guan, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 13
Haohuai He, Bing He, Lei Guan, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 13
Whole-canine neutralizing antibodies generated by single B cell antibody technology elicit therapeutic protection against canine distemper virus infection
Pengfei Shi, Zhihao Wang, Wei Sheng, et al.
Veterinary Microbiology (2025), pp. 110412-110412
Closed Access | Times Cited: 1
Pengfei Shi, Zhihao Wang, Wei Sheng, et al.
Veterinary Microbiology (2025), pp. 110412-110412
Closed Access | Times Cited: 1
The use of proteins and peptides-based therapy in managing and preventing pathogenic viruses
Esmail M. El‐Fakharany, Hamada El‐Gendi, Ahmed K. Saleh, et al.
International Journal of Biological Macromolecules (2024) Vol. 270, pp. 132254-132254
Closed Access | Times Cited: 7
Esmail M. El‐Fakharany, Hamada El‐Gendi, Ahmed K. Saleh, et al.
International Journal of Biological Macromolecules (2024) Vol. 270, pp. 132254-132254
Closed Access | Times Cited: 7
Mechanism-Driven Design of Multispecific Antibodies for Targeted Disease Treatment
Justyn Fine, Bunyarit Meksiriporn, Jiacheng Tan, et al.
Annual Review of Chemical and Biomolecular Engineering (2024) Vol. 15, Iss. 1, pp. 105-138
Closed Access | Times Cited: 5
Justyn Fine, Bunyarit Meksiriporn, Jiacheng Tan, et al.
Annual Review of Chemical and Biomolecular Engineering (2024) Vol. 15, Iss. 1, pp. 105-138
Closed Access | Times Cited: 5
A High Threshold of Biotherapeutic Aggregate Numbers is Needed to Induce an Immunogenic Response In Vitro, In Vivo, and in the Clinic
Joseph R. Cohen, Stephen R. Brych, Siddharth Prabhu, et al.
Pharmaceutical Research (2024) Vol. 41, Iss. 4, pp. 651-672
Closed Access | Times Cited: 5
Joseph R. Cohen, Stephen R. Brych, Siddharth Prabhu, et al.
Pharmaceutical Research (2024) Vol. 41, Iss. 4, pp. 651-672
Closed Access | Times Cited: 5
Next-Generation Therapeutic Antibodies for Cancer Treatment: Advancements, Applications, and Challenges
A. Raja, Abhishek Kasana, Vaishali Verma
Molecular Biotechnology (2024)
Closed Access | Times Cited: 5
A. Raja, Abhishek Kasana, Vaishali Verma
Molecular Biotechnology (2024)
Closed Access | Times Cited: 5
New Senolysis Approach via Antibody–Drug Conjugate Targeting of the Senescent Cell Marker Apolipoprotein D for Skin Rejuvenation
Kento Takaya, Toru Asou, Kazuo Kishi
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5857-5857
Open Access | Times Cited: 11
Kento Takaya, Toru Asou, Kazuo Kishi
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5857-5857
Open Access | Times Cited: 11
High throughput identification of human monoclonal antibodies and heavy-chain-only antibodies to treat snakebite
Julien Slagboom, A. Lewis, Wietse M. Schouten, et al.
Toxicon X (2024) Vol. 21, pp. 100185-100185
Open Access | Times Cited: 4
Julien Slagboom, A. Lewis, Wietse M. Schouten, et al.
Toxicon X (2024) Vol. 21, pp. 100185-100185
Open Access | Times Cited: 4
Multidimensional LC-MS with 1D multi-method option and parallel middle-up and bottom-up MS acquisition for in-depth characterization of antibodies
Liesa Verscheure, Shauni Detremmerie, Hilde Stals, et al.
Journal of Chromatography A (2024) Vol. 1726, pp. 464947-464947
Closed Access | Times Cited: 4
Liesa Verscheure, Shauni Detremmerie, Hilde Stals, et al.
Journal of Chromatography A (2024) Vol. 1726, pp. 464947-464947
Closed Access | Times Cited: 4
Monoclonal antibodies: From magic bullet to precision weapon
Hassan Aboul-Ella, Asmaa Gohar, Aya Ahmed Ali, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 4
Hassan Aboul-Ella, Asmaa Gohar, Aya Ahmed Ali, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 4
The role of monoclonal antibodies in the treatment of pancreatic and colon cancers
Soumya Dakshinamurthy
Elsevier eBooks (2025), pp. 389-412
Closed Access
Soumya Dakshinamurthy
Elsevier eBooks (2025), pp. 389-412
Closed Access
Anionic lipids direct efficient microfluidic encapsulation of stable and functionally active proteins in lipid nanoparticles
Suresh Ambati, Yeqi Li, Matthew K. Whittaker, et al.
Communications Materials (2025) Vol. 6, Iss. 1
Open Access
Suresh Ambati, Yeqi Li, Matthew K. Whittaker, et al.
Communications Materials (2025) Vol. 6, Iss. 1
Open Access
Generation and Selection of Novel Human-Neutralizing Single Chain Variable Fragments Against Rabies Virus from Immunized Phage Display Libraries
Apidsada Chorpunkul, Usa Boonyuen, Kriengsak Limkittikul, et al.
Heliyon (2025), pp. e42923-e42923
Open Access
Apidsada Chorpunkul, Usa Boonyuen, Kriengsak Limkittikul, et al.
Heliyon (2025), pp. e42923-e42923
Open Access
Identification of chicken-derived antibodies targeting the Candida albicans Als3 protein
Chi‐Hsin Lee, Chao‐Jung Wu, Frank Yen, et al.
Applied Microbiology and Biotechnology (2025) Vol. 109, Iss. 1
Open Access
Chi‐Hsin Lee, Chao‐Jung Wu, Frank Yen, et al.
Applied Microbiology and Biotechnology (2025) Vol. 109, Iss. 1
Open Access
Evaluating the immune effector functions induced by humanized anti-CD99 antibody in eliminating T lymphoblastic leukemia/lymphoma cells
Kamonporn Kotemul, Ratthakorn Chaiwut, Chaochetdhapada Putpim, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Kamonporn Kotemul, Ratthakorn Chaiwut, Chaochetdhapada Putpim, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
At The Interface: Small-Molecule Inhibitors of Soluble Cytokines
Raavi, Angela N. Koehler, Arturo J. Vegas
Chemical Reviews (2025)
Closed Access
Raavi, Angela N. Koehler, Arturo J. Vegas
Chemical Reviews (2025)
Closed Access
Cytoplasmic delivery of antibodies through grafting a functional single complementarity‐determining region loop
Yerin Jeon, Juho Choi, Youngin Roh, et al.
FEBS Letters (2025)
Open Access
Yerin Jeon, Juho Choi, Youngin Roh, et al.
FEBS Letters (2025)
Open Access
Engineering therapeutic monoclonal antibodies
Cosby A. Stone, Benjamin W. Spiller, Scott A. Smith
Journal of Allergy and Clinical Immunology (2023) Vol. 153, Iss. 3, pp. 539-548
Closed Access | Times Cited: 9
Cosby A. Stone, Benjamin W. Spiller, Scott A. Smith
Journal of Allergy and Clinical Immunology (2023) Vol. 153, Iss. 3, pp. 539-548
Closed Access | Times Cited: 9
The application of antibody-based agents in cancer therapy based on their mechanisms of action
Kewen Qian, Guangyao Li, Shuyi Zhang, et al.
Fundamental Research (2024)
Open Access | Times Cited: 3
Kewen Qian, Guangyao Li, Shuyi Zhang, et al.
Fundamental Research (2024)
Open Access | Times Cited: 3
Structure‐based computational design of antibody mimetics: challenges and perspectives
Elton José Ferreira Chaves, Danilo F. Côelho, Carlos Cruz, et al.
FEBS Open Bio (2024)
Open Access | Times Cited: 3
Elton José Ferreira Chaves, Danilo F. Côelho, Carlos Cruz, et al.
FEBS Open Bio (2024)
Open Access | Times Cited: 3
Targeted Therapies: The Role of Monoclonal Antibodies in Disease Management
Akram N. Salah, Amr H. Hashem, Mohamed Bakr Zaki, et al.
Journal of Biochemical and Molecular Toxicology (2025) Vol. 39, Iss. 2
Closed Access
Akram N. Salah, Amr H. Hashem, Mohamed Bakr Zaki, et al.
Journal of Biochemical and Molecular Toxicology (2025) Vol. 39, Iss. 2
Closed Access
The Effects of Excipients on Freeze-dried Monoclonal Antibody Formulation Degradation and Sub-Visible Particle Formation during Shaking
Meng-Jia Jin, Xin-Zhe Ge, Qiong Huang, et al.
Pharmaceutical Research (2024) Vol. 41, Iss. 2, pp. 321-334
Closed Access | Times Cited: 2
Meng-Jia Jin, Xin-Zhe Ge, Qiong Huang, et al.
Pharmaceutical Research (2024) Vol. 41, Iss. 2, pp. 321-334
Closed Access | Times Cited: 2
Exploring the Biological Activity of a Humanized Anti-CD99 ScFv and Antibody for Targeting T Cell Malignancies
Nuchjira Takheaw, Thanathat Pamonsupornwichit, Ratthakorn Chaiwut, et al.
Biomolecules (2024) Vol. 14, Iss. 11, pp. 1422-1422
Open Access | Times Cited: 2
Nuchjira Takheaw, Thanathat Pamonsupornwichit, Ratthakorn Chaiwut, et al.
Biomolecules (2024) Vol. 14, Iss. 11, pp. 1422-1422
Open Access | Times Cited: 2
